Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics
NCT02682862Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jul 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of olodaterol and tiotropium in asthma (2 arms), sponsored by University of Dundee. Primary endpoint: Airway resistance at 5Hz. Started Jul 2016; status: completed.
02
Drugs
olodateroltiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02682862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682862.